Elaine Aparecida Del Bel

Author

Also Known As

Del Bel, Elaine, Del-Bel, Elaine Aparecida, E A Del-Bel, E. A. Del-Bel, E. Del-Bel, E. DelBel, E.A. Del Bel, E.A. Del-Bel, E.A. DelBel, ELAINE APARECIDA DEL BEL BELLUZ GUIMARÃES

158

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Universidade de São Paulo Universidade de Ribeirão Preto Sorbonne Université Inserm Centre National de la Recherche Scientifique

About

Elaine Aparecida Del Bel is an author at Universidade de São Paulo specializing in medicine, neuropharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	35	1.7K
2	Social Sciences	13	13	730
3	Health Sciences	3	3	127
4	Engineering	1	1	24
5	Natural Sciences	1	1	34

Elaine Aparecida Del Bel

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways Flávia V. Santa-Cecília, Benjamin Socias, Mohand Ouidir Ouidja, Neurotoxicity Research InflammationNf-kb Signaling PathwaysAnti-inflammatoryCell SignalingMedicine	2016	159
Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol Felipe V. Gomes, Ricardo Llorente, Elaine Aparecida Del Bel, Schizophrenia Research Cannabis UsePsychiatryPsychotropic MedicationPsychopharmacologyNeuropsychiatry	2015	146
Repurposing doxycycline for synucleinopathies: remodelling of α-synuclein oligomers towards non-toxic parallel beta-sheet structured species Florencia González‐Lizárraga, Sergio B. Socías, César L. Ávila, Scientific Reports	2017	118
Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease Mariza Bortolanza, Roberta Cavalcanti-Kiwiatkoski, Fernando E. Padovan‐Neto, Neurobiology of Disease MedicineNeuropharmacologyNeuroprotectionNeurologyNeuroscience	2014	116
Nitric oxide synthase inhibition attenuates l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease Fernando E. Padovan‐Neto, Marcela Bermúdez Echeverry, Vítor Tumas, Neuroscience MedicineParkinson DiseaseRodent ModelNeuropharmacologyNeuroscience	2009	96
Effects of acute and chronic fluoxetine treatments on restraint stress-induced Fos expression Cilene Lino de Oliveira, Amanda J. Sales, Elaine Aparecida Del Bel, Brain Research Bulletin Chronic Fluoxetine TreatmentsStress HormonePsychiatryStressMedicine	2001	95
Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action Maurício dos Santos Pereira, C.A. da-Silva, Francisco Silveira Guimarães, Neurobiology of Disease Molecular PharmacologyPharmacologyNeuropharmacologyExperimental PharmacologyPharmacotherapy	2016	94
Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice Felipe V. Gomes, Ana Carolina Issy, Frederico Rogério Ferreira, The International Journal of Neuropsychopharmacology	2015	86
Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase Marco Mori, A Delattre, Bruno Carabelli, Nutritional Neuroscience Neurodegenerative DiseasesBiochemistryOmega-3 Fatty AcidMedicineLipid Peroxidation	2017	86
Caffeic acid phenethyl ester protects against the dopaminergic neuronal loss induced by 6-hydroxydopamine in rats Roberto de Barros Silva, Neife Aparecida Guinaim dos Santos, Nádia Maria Martins, Neuroscience NeurophysiologyMedicinePhysiologyNeuropharmacologyNeuroprotection	2013	84

Page 1